类有机物
胶质母细胞瘤
细胞毒性
U87型
微流控
肿瘤微环境
嵌合抗原受体
癌症研究
微流控芯片
免疫疗法
免疫系统
细胞培养
细胞
肿瘤细胞
抗原
癌症治疗
癌症
癌症免疫疗法
化学
生物
个性化医疗
癌细胞
计算生物学
细胞毒性T细胞
靶向治疗
肿瘤抗原
脑瘤
细胞疗法
作者
Guidong Zhu,Xiaoxue Shi,Ying Jiang,Wen Zhang,Linpei Guo,Guojing Pei,Yingchao Liu,Dongqi Tang,Chengwei Wang,Zhongzheng Sun
标识
DOI:10.1038/s42003-025-09390-0
摘要
Tumor organoids mimicking the tumor microenvironment (TME) are key tools for tumor immunity research and personalized cancer therapy development. We integrated microgravity culture with microfluidic chip technology (Micro-GRA& FLU) to establish a platform for evaluating chimeric antigen receptor (CAR)-γδ T cell efficacy under physiological-like conditions. Patient-derived glioblastoma (GBM) cells were microgravity-cultured into glioblastoma organoids (GBOs). Pathological analysis validated GBO similarity to matched GBM in immune cell phenotypes. Microfluidic chips assessed CAR-γδ T cell cytotoxicity against GBOs. The low-cost, easy-to-operate microgravity system generated viable, uniform GBOs that retained GBM TME features. CAR-γδ T cells showed strong cytotoxicity against GBOs in microfluidic chips; individualized combination therapy enhanced their antitumor activity vs. monotherapy. This study establishes a scalable, physiologically relevant Micro-GRA& FLU platform for evaluating CAR-γδ T cell therapies in GBM organoids. To evaluate the efficacy of CAR-γδ T cells for GBM, this study developed the Micro-GRA&FLU platform. This low-cost, scalable platform provides a physiologically relevant model for assessing personalized immunotherapy for GBM.
科研通智能强力驱动
Strongly Powered by AbleSci AI